Ebastine Versus Mebeverine in IBS Patients

Clinical trial NCT05815602 · RECRUITING

Trial details

NCT number: NCT05815602
Sponsor: Guy Boeckxstaens
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

IBS - Irritable Bowel Syndrome IBS

Start date: 2023-03-30
Primary completion: 2027-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.